Brendaz Ta, et al. v. Merck and Co., Inc., et al.

Summary

The United States District Court for the Central District of California ordered the plaintiffs to show cause why their action should not be severed into separate suits on behalf of Brendaz Ta and Dockery. The court cited Federal Rule of Civil Procedure 21 and directed plaintiffs and defendants to file responses by March 20 and March 27, 2023, respectively.

Holdings

1. Under Federal Rule of Civil Procedure 21, the court may, on its own motion, sever a claim against a party and require the parties to show cause why separate proceedings should not be created.

Questions Presented

1. Whether the court should order plaintiffs to show cause why the claims of Ta and Dockery should not be severed into two separate actions under Federal Rule of Civil Procedure 21.

Disposition

other